Cargando…
RAD52 as a Potential Target for Synthetic Lethality-Based Anticancer Therapies
Alterations in DNA repair systems play a key role in the induction and progression of cancer. Tumor-specific defects in DNA repair mechanisms and activation of alternative repair routes create the opportunity to employ a phenomenon called “synthetic lethality” to eliminate cancer cells. Targeting th...
Autores principales: | Toma, Monika, Sullivan-Reed, Katherine, Śliwiński, Tomasz, Skorski, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827130/ https://www.ncbi.nlm.nih.gov/pubmed/31615159 http://dx.doi.org/10.3390/cancers11101561 |
Ejemplares similares
-
Synthetic Lethality Targeting Polθ
por: Drzewiecka, Małgorzata, et al.
Publicado: (2022) -
Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells
por: Sullivan-Reed, Katherine, et al.
Publicado: (2018) -
Novel Insights into RAD52’s Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies
por: Balboni, Beatrice, et al.
Publicado: (2023) -
RAD52: Paradigm of Synthetic Lethality and New Developments
por: Rossi, Matthew J., et al.
Publicado: (2021) -
Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection
por: Sullivan, Katherine, et al.
Publicado: (2016)